Sfoglia per Autore
High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis.
2010-01-01 Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators Collaborators (73) Vannucchi AM, Antonioli E, Bartalucci N, Biamonte F, Bogani C, Bosi A, Fjerza R, Guglielmelli P, Malevolti E, Pancrazzi A,Pieri L, Spolverini A, Susini MC, Tozzi L, Bortoluzzi S, Bisognin A, Coppe A, Marchioli R, Barosi G, Azzan C, Badalucco S,Balduini A, Bergamaschi G, Bonetti E, Campanelli R, Carolei A, Currao M, Isgrò MA, Lupo ML, Magrini U, Massa M, Magni V,Rosti V, Villani L, Cazzola M, Bernasconi P, Boggi S, Elena C, Gallì A, Malcovati L, Pascutto C, Passamonti F, Pietra D,Rumi E, Dejana E, Corada M, Giannotta M, Rambaldi A, Ferrari ML, Finazzi G, Finazzi MC, Magri M, Quaresmini G, Montalvo ML, Ricci C, Salmoiraghi S, Spinelli O, Amaru A, Golay J, Cilloni D, Arruga F, Bracco E, Carturan S, Gaidano V, Guerrasio A,Pradotto M, Manfredini R, Bianchi E, Montanari M, Salati S, Tagliafico E, Tenedini E, Zini R
Reply to the letter by Law et al. Is Rituximab therapy in Castleman's disease a risk factor for Kaposi sarcoma reactivation?
2010-01-01 Nicoli Paolo; Guerrasio Angelo
HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma
2009-01-01 Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A.
Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia.
2008-01-01 Morotti A;Cilloni D;Parvis G;Guerrasio A;Saglio G
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536
2007-01-01 Morotti A; Parvis G; Cilloni D; Familiari U; Pautasso M; Bosa M; Messa F; Arruga F; Defilippi I; Catalano R; Rosso V; Carturan S; Bracco E; Guerrasio A; Saglio G.
CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536.
2007-01-01 Morotti A;Parvis G;Cilloni D;Familiari U;Pautasso M;Bosa M;Messa F;Arruga F;Defilippi I;Catalano R;Rosso V;Carturan S;Bracco E;Guerrasio A;Saglio G
Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells
2006-01-01 MOROTTI A; CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO; R; ROSSO V; CHIARENZA A; PILATRINO C; GUERRASIO A; TAULLI R; BRACCO E; PAUTASSO; M; BARABAN D; GOTTARDI E; SAGLIO G.
Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life
2005-01-01 SACCARDI R; MANCARDI GL; SOLARI A; BOSI A; BRUZZI P; DI BARTOLOMEO P; DONELLI A; FILIPPI M; GUERRASIO A; GUALANDI F; LA NASA G; MURIALDO A; PAGLIAI F; PAPINESCHI F; SCAPPINI B; MARMONT AM
Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid
2005-01-01 C. PILATRINO; D. CILLONI; E. MESSA; A. MOROTTI; E. GIUGLIANO; M. PAUTASSO; U. FAMILIARI; S. CAPPIA; P.G. PELICCI; F. LO COCO; G. SAGLIO; A. GUERRASIO
SODIUM VALPROATE ENHANCES IMATINIB INDUCED APOPTOSIS AND GROWTH ARREST IN BCR-ABL CELL LINES
2004-01-01 Morotti A; Cilloni D; Pautasso M; Baraban D; Messa F; Arruga F; De Filippi I; Messa E; Carturan S; Rege-cambrin G; Pilatrino C; Guerrasio A; Gottardi E; Saglio G
Letter to the Editor: reply to Martinelli et al.
2003-01-01 GUERRASIO A; PILATRINO C; D. CILLONI; GOTTARDI E; SAGLIO G
Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection
2003-01-01 CILLONI D; GOTTARDI E; FAVA M; MESSA F; CARTURAN S; BUSCA A; GUERRASIO A; G. SAGLIO
Sodium valproate enhances Imatinib induced apoptosis and growth arrest in Bcr-Abl cell lines
2003-01-01 Morotti A.; Cilloni D.; Messa F.; Pautasso M.; Rege-Cambrin G.; Pilatrino C.; Guerrasio A.; Gottardi E.; Alberti D; Saglio G
Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias
2003-01-01 CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; MESSA E; FAVA M; DIVERIO D; GUERRASIO A; LO-COCO F; G. SAGLIO
Extranodal Hodgkin lymphoma with renal, splenic and uterine involvement. A case report.
2002-01-01 CATALDI A.; SARDO P.; VENTILII G.; GUERRASIO A.; PILASTRINO C.; SAGLIO G.; C. FAVA
Renal Hodgkin's disease.
2002-01-01 PILATRINO C ;CATALDI A ;GUERRASIO A ;SAGLIO G
From genes to therapy: the case of Philadelphia chromosome-positive leukemias.
2002-01-01 D. CILLONI; GUERRASIO A; GIUGLIANO E; SCARAVAGLIO P; VOLPE G; REGE-CAMBRIN; G; SAGLIO G.
New perspectives for molecular targeted therapy in human leukemias
2002-01-01 G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio
Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts.
2002-01-01 GUERRASIO A; PILATRINO C; DE MICHELI D; D. CILLONI; SERRA A; GOTTARDI E; PARZIALE A; MARMONT F; DIVERIO D; DIVONA M; LO COCO F; SAGLIO G.
Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients
2002-01-01 CILLONI D; GOTTARDI E; DE MICHELI D; SERRA A; VOLPE G; MESSA F; REGE-CAMBRIN G; GUERRASIO A; DIVONA A; LO COCO F; G. SAGLIO
| Titolo | Data di pubblicazione | Autore(i) | File |
|---|---|---|---|
| High frequency of endothelial colony forming cells marks a non-active myeloproliferative neoplasm with high risk of splanchnic vein thrombosis. | 2010 | Rosti V, Bonetti E, Bergamaschi G, Campanelli R, Guglielmelli P, Maestri M, Magrini U, Massa M, Tinelli C, Viarengo G, Villani L, Primignani M, Vannucchi AM, Frassoni F, Barosi G; AGIMM Investigators Collaborators (73) Vannucchi AM, Antonioli E, Bartalucci N, Biamonte F, Bogani C, Bosi A, Fjerza R, Guglielmelli P, Malevolti E, Pancrazzi A,Pieri L, Spolverini A, Susini MC, Tozzi L, Bortoluzzi S, Bisognin A, Coppe A, Marchioli R, Barosi G, Azzan C, Badalucco S,Balduini A, Bergamaschi G, Bonetti E, Campanelli R, Carolei A, Currao M, Isgrò MA, Lupo ML, Magrini U, Massa M, Magni V,Rosti V, Villani L, Cazzola M, Bernasconi P, Boggi S, Elena C, Gallì A, Malcovati L, Pascutto C, Passamonti F, Pietra D,Rumi E, Dejana E, Corada M, Giannotta M, Rambaldi A, Ferrari ML, Finazzi G, Finazzi MC, Magri M, Quaresmini G, Montalvo ML, Ricci C, Salmoiraghi S, Spinelli O, Amaru A, Golay J, Cilloni D, Arruga F, Bracco E, Carturan S, Gaidano V, Guerrasio A,Pradotto M, Manfredini R, Bianchi E, Montanari M, Salati S, Tagliafico E, Tenedini E, Zini R | |
| Reply to the letter by Law et al. Is Rituximab therapy in Castleman's disease a risk factor for Kaposi sarcoma reactivation? | 2010 | Nicoli Paolo; Guerrasio Angelo | |
| HHV8-positive, HIV-negative multicentric Castleman’s disease: early and sustained complete remission with rituximab therapy without reactivation of Kaposi sarcoma | 2009 | Nicoli P; Familiari U; Bosa M; Allice T; Mete F; Morotti A; Cilloni D; Saglio G; Guerrasio A. | |
| Thalidomide-induced partial stable remission in a case of refractory progressive B Cell Chronic Lymphoid Leukemia. | 2008 | Morotti A;Cilloni D;Parvis G;Guerrasio A;Saglio G | |
| CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536 | 2007 | Morotti A; Parvis G; Cilloni D; Familiari U; Pautasso M; Bosa M; Messa F; Arruga F; Defilippi I; Catalano R; Rosso V; Carturan S; Bracco E; Guerrasio A; Saglio G. | |
| CD7/CD56-positive acute myeloid leukemias are characterized by constitutive phosphorylation of the NF-kB subunit p65 at Ser536. | 2007 | Morotti A;Parvis G;Cilloni D;Familiari U;Pautasso M;Bosa M;Messa F;Arruga F;Defilippi I;Catalano R;Rosso V;Carturan S;Bracco E;Guerrasio A;Saglio G | |
| Valproate enhances imatinib-induced growth arrest and apoptosis in chronic myeloid leucemia cells | 2006 | MOROTTI A; CILLONI D; MESSA F; ARRUGA F; DEFILIPPI I; CARTURAN S; CATALANO; R; ROSSO V; CHIARENZA A; PILATRINO C; GUERRASIO A; TAULLI R; BRACCO E; PAUTASSO; M; BARABAN D; GOTTARDI E; SAGLIO G. | |
| Autologous HSCT for severe progressive multiple sclerosis in a multicenter trial: impact on disease activity and quality of life | 2005 | SACCARDI R; MANCARDI GL; SOLARI A; BOSI A; BRUZZI P; DI BARTOLOMEO P; DONELLI A; FILIPPI M; GUERRASIO A; GUALANDI F; LA NASA G; MURIALDO A; PAGLIAI F; PAPINESCHI F; SCAPPINI B; MARMONT AM | |
| Increase in platelet count in older, poor-risk patients with acute myeloid leukemia or myelodysplastic syndrome treated with valproic acid and all-trans retinoic acid | 2005 | C. PILATRINO; D. CILLONI; E. MESSA; A. MOROTTI; E. GIUGLIANO; M. PAUTASSO; U. FAMILIARI; S. CAPPIA; P.G. PELICCI; F. LO COCO; G. SAGLIO; A. GUERRASIO | |
| SODIUM VALPROATE ENHANCES IMATINIB INDUCED APOPTOSIS AND GROWTH ARREST IN BCR-ABL CELL LINES | 2004 | Morotti A; Cilloni D; Pautasso M; Baraban D; Messa F; Arruga F; De Filippi I; Messa E; Carturan S; Rege-cambrin G; Pilatrino C; Guerrasio A; Gottardi E; Saglio G | |
| Letter to the Editor: reply to Martinelli et al. | 2003 | GUERRASIO A; PILATRINO C; D. CILLONI; GOTTARDI E; SAGLIO G | |
| Usefulness of quantitative assessment of the WT1 gene transcript as a marker for minimal residual disease detection | 2003 | CILLONI D; GOTTARDI E; FAVA M; MESSA F; CARTURAN S; BUSCA A; GUERRASIO A; G. SAGLIO | |
| Sodium valproate enhances Imatinib induced apoptosis and growth arrest in Bcr-Abl cell lines | 2003 | Morotti A.; Cilloni D.; Messa F.; Pautasso M.; Rege-Cambrin G.; Pilatrino C.; Guerrasio A.; Gottardi E.; Alberti D; Saglio G | |
| Down-modulation of the C/EBPalpha transcription factor in core binding factor acute myeloid leukemias | 2003 | CILLONI D; CARTURAN S; GOTTARDI E; MESSA F; MESSA E; FAVA M; DIVERIO D; GUERRASIO A; LO-COCO F; G. SAGLIO | |
| Extranodal Hodgkin lymphoma with renal, splenic and uterine involvement. A case report. | 2002 | CATALDI A.; SARDO P.; VENTILII G.; GUERRASIO A.; PILASTRINO C.; SAGLIO G.; C. FAVA | |
| Renal Hodgkin's disease. | 2002 | PILATRINO C ;CATALDI A ;GUERRASIO A ;SAGLIO G | |
| From genes to therapy: the case of Philadelphia chromosome-positive leukemias. | 2002 | D. CILLONI; GUERRASIO A; GIUGLIANO E; SCARAVAGLIO P; VOLPE G; REGE-CAMBRIN; G; SAGLIO G. | |
| New perspectives for molecular targeted therapy in human leukemias | 2002 | G.Saglio; D;Cilloni; A. Morotti; C. Pilatrino; G. Volpe; E. Gottardi; P. Scaravaglio; E.Giugliano; E. Messa; G. Rege-Cambrin; A. Guerrasio | |
| Assessment of minimal residual disease (MRD) in CBFbeta/MYH11-positive acute myeloid leukemias by qualitative and quantitative RT-PCR amplification of fusion transcripts. | 2002 | GUERRASIO A; PILATRINO C; DE MICHELI D; D. CILLONI; SERRA A; GOTTARDI E; PARZIALE A; MARMONT F; DIVERIO D; DIVONA M; LO COCO F; SAGLIO G. | |
| Quantitative assessment of WT1 expression by real time quantitative PCR may be a useful tool for monitoring minimal residual disease in acute leukemia patients | 2002 | CILLONI D; GOTTARDI E; DE MICHELI D; SERRA A; VOLPE G; MESSA F; REGE-CAMBRIN G; GUERRASIO A; DIVONA A; LO COCO F; G. SAGLIO |
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile